<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250726066640N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-20</date_registration>
      <primary_sponsor>Jahrom University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the impact of the careSTEPS intervention on caregivers of cancer patients</public_title>
      <acronym>careSTEPS</acronym>
      <scientific_title>Investigating the effect of careSTEPS intervention on general health, care burden and quality of life of caregivers of cancer patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>94</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/85732</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Factorial, Purpose: Supportive, Randomization description: After approving the plan and receiving the code of ethics from the Honorable Vice President of Research, a letter will be received to start sampling at Imam Hassan Mojtaba (AS) Hospital in Darab. The researcher, as an active observer and interventionist, will call a few weeks before the intervention to announce the call, and after the caregivers complete a written consent form, will take the sample and review the inclusion criteria. Simple random sampling will be performed using the Random Number Generator V2 software from the list of caregivers of cancer patients referred to the insurance unit of Imam Hassan Mojtaba (AS) Hospital in Darab who meet the inclusion criteria for the study, and then the caregivers will be divided into two intervention and control groups by simple random allocation using the Random Allocation Software V2 software, Blinding description: Participant blinding: Lack of knowledge of how the intervention was implemented
Researcher blinding: Distribution of questionnaires by another person who is unaware of how the intervention was implemented
Data analyst blinding: Data are recorded with a numerical number and there is no indication of which group they belong to.</study_design>
      <phase>N/A</phase>
      <hc_freetext>caregivers of patients with various types of cancers.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Conducting 6 in-person training sessions on the topics of self-care, improving communication, managing symptoms, problem-solving skills, and social support. Intervention 2: Control group: For the control group, no specific intervention will be carried out by the researchers, but after the intervention is implemented, if it is effective, due to compliance with research ethics, two in-person training sessions will be held for the caregivers of the control group. Pamphlets and educational content for the virtual group will also be made available to them.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Statistical data will be published without naming individuals.

When:
It depends on the opinion of the advisors and supervisors.

To whom:
The data from this study will be available to clinicians and researchers alike.

Conditions:
They will be allowed to use the data according to the laws.

Where to obtain:
After the article is published in journals, it is printed through the journal.

How to obtain:
First, the request should be sent to the responsible author. After review, the information will be provided by him/her.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohsen Hojat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Office of the president and deputy of development jahrom university of medical sciences, end of shahid beheshti blvd, jahrom, fars province,iran</address>
        <city>Jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>74148-46199</zip>
        <telephone>+98 71 5447 5601</telephone>
        <email>Mohsenhojat.mh@gmail.com</email>
        <affiliation>Jahrom University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohsen Hojat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Office of the president and deputy of development, jahrom university of medical sciences, end of shahid beheshti blvd, jahrom, fars province,iran</address>
        <city>Jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>74148-46199</zip>
        <telephone>+98 71 5447 5601</telephone>
        <email>Mohsenhojat.mh@gmail.com</email>
        <affiliation>Jahrom University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patient caregiver's willingness and consent to participate in this study
Being literate
Absence of psychological disorders (depression, psychosis, and mania) and mental disorders based on self-report
Not participating in a similar study in the past 6 months
The person identified by the patient or their companion as the patient's primary caregiver
Access to mobile or landline phone
Over 18 years old</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Lack of cooperation in completing questionnaires
Failure to attend meetings more than 2 times
Patient death
Discontinuation of treatment for any reason
Moving, relocating, and emigrating to another village, city, or country
Change or death of primary caregiver
Occurrence of mental disorders in the caregiver and referral to a psychiatrist</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C80.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant (primary) neoplasm, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Conducting 6 in-person training sessions on the topics of self-care, improving communication, managing symptoms, problem-solving skills, and social support.</i_keyword>
      <i_keyword>Control group: For the control group, no specific intervention will be carried out by the researchers, but after the intervention is implemented, if it is effective, due to compliance with research ethics, two in-person training sessions will be held for the caregivers of the control group. Pamphlets and educational content for the virtual group will also be made available to them.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Burden of care- general health- quality of life. Timepoint: Before and one month after the intervention. Method of measurement: CHQ-28-Zarit questionnaires - Quality of Life Questionnaire for Caregivers of Cancer Patients.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life. Timepoint: Before and one month after the intervention. Method of measurement: Cancer Caregiver Quality of Life Questionnaire CQOLC7.</sec_outcome>
      <sec_outcome>General health. Timepoint: Before and one month after the intervention. Method of measurement: GHQ-28) General Health Self-Report Scale.</sec_outcome>
      <sec_outcome>Burden of care. Timepoint: Before and one month after the intervention. Method of measurement: Zarit Caregiver Burden Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Jahrom University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-08-19</approval_date>
        <contact_name>Ethical committee of jahrom university of medical sciences</contact_name>
        <contact_address>Office of the president and deputy of development jahrom universityof medical sciences end of shahid beheshti blvd Jahrom Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
